Panobinostat
Back to searchMolecule Structure
Scientific Name
Panobinostat
Description of the Drug
Panobinostat is a non-selective histone deacetylase inhibitor used to treat multiple myeloma in combination with other antineoplastic agents.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06603
http://www.drugbank.ca/drugs/DB06603
Brand Name(s)
Farydak
Company Owner(s)
Secura Bio Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histone deacetylase | PROTEIN FAMILY | INHIBITOR | CHEMBL2093865 |
Clinical Trial(s)
Unichem Links
| Atlas | LBH589 | ||
| SureChEMBL | SCHEMBL22773814 | SCHEMBL164801 | |
| PharmGKB | PA166161307 | ||
| DrugBank | DB06603 | ||
| PubChem: Thomson Pharma | 15274143 | ||
| PubChem | 6918837 | ||
| LINCS | LSM-43059 | ||
| Nikkaji | J2.554.199E | J3.451.397J | |
| PDBe | LBH | ||
| BindingDB | 196535 | 29589 | 198124 |
| EPA CompTox Dashboard | DTXSID40193506 | ||
| DrugCentral | 4682 | ||
| Brenda | 26694 | 26696 | 163471 |
| ChemicalBook | CB61009161 | ||
| Guide to Pharmacology | 7489 | ||
| rxnorm | PANOBINOSTAT | PANOBINOSTAT LACTATE | FARYDAK |
| PubChem: Drugs of the Future | 12015928 | ||
| ChEBI | 85990 | ||
| ZINC | ZINC000022010649 |
